Relmada Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Relmada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Relmada Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Relmada Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $37k | 18k | 2.01 |
| 2024-12-31 | $92k | 176k | 0.52 |
| 2024-09-30 | $553k | 171k | 3.24 |
| 2024-06-30 | $467k | 156k | 3.00 |
| 2024-03-31 | $788k | 170k | 4.65 |
| 2023-12-31 | $2.0M | 481k | 4.14 |
| 2023-09-30 | $1.6M | 519k | 3.00 |
| 2023-06-30 | $1.9M | 761k | 2.46 |
| 2023-03-31 | $1.8M | 812k | 2.26 |
| 2022-12-31 | $2.1M | 607k | 3.49 |
| 2022-06-30 | $23M | 1.2M | 18.99 |
| 2022-03-31 | $28M | 1.0M | 26.96 |
| 2021-12-31 | $7.7M | 344k | 22.53 |
| 2021-09-30 | $12M | 454k | 26.21 |
| 2021-06-30 | $13M | 403k | 32.00 |
| 2021-03-31 | $1.8M | 51k | 35.22 |
| 2020-12-31 | $719k | 22k | 32.07 |
| 2020-09-30 | $741k | 20k | 37.61 |
| 2020-03-31 | $11M | 320k | 34.11 |
| 2019-12-31 | $3.1M | 80k | 39.00 |